Cefpodoxime Clavulanic Acid WFI

ODOXICEF CV DS WFI

COMPOSITION
Cefpodoxime50MG
Clavulanic Acid WFI31.25MG
SPECIFICATION
FORMPEDIATRIC
PACKING 30ML
PACKING TYPE
MRP88

DESCRIPTION

Cefpodoxime and Clavulanic acid combination are effective against multiple infections. The pharmacological action of Clavulanic acid prevents hydrolysis of Cefpodoxime against beta-lactamase secreting microbes and increases the antibiotic spectrum.

SIDE EFFECTS

No information available

INDICATION

Cefpodoxime and Clavulanic acid are contraindicated in patients with serious allergy to penicillin, cephalosporin group of antibiotics and renal impairment.